Overall, CPT is a natural anti‐oestrogen agent and could inhibit ERα‐mediated IGF‐1/AKT/mTOR pathway to increase the sensitivity of the ERα‐positive resistant breast cancer cells. This evidence concerns the gene MTOR and breast carcinoma.